Expression of Bcl-2 and Bax in advanced or metastatic prostate carcinoma

scientific article published on 01 January 2012

Expression of Bcl-2 and Bax in advanced or metastatic prostate carcinoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID22395836

P2093author name stringHassan Ahmadnia
Kazem Anvari
Abdolazim Sedighi Pashaki
Mahdi Karimi Shahri
Mehdi Seilanian Toussi
Mehrdad Katebi
Mahdieh Dayani
Shahram Naseri
Mahmoud Kalantari
Maryam Broumand
P433issue1
P921main subjectmetastatic prostate carcinomaQ55779807
P304page(s)381-388
P577publication date2012-01-01
P1433published inUrology journalQ26841898
P1476titleExpression of Bcl-2 and Bax in advanced or metastatic prostate carcinoma
P478volume9

Reverse relations

cites work (P2860)
Q33708677BCL2 genotypes and prostate cancer survival
Q41463153BH3 Mimetics for the Treatment of Prostate Cancer
Q47547132FAM3B/PANDER inhibits cell death and increases prostate tumor growth by modulating the expression of Bcl-2 and Bcl-XL cell survival genes
Q35023204Lack of association between Bax promoter (-248G>A) single nucleotide polymorphism and susceptibility towards cancer: evidence from a meta-analysis
Q90048237Mechanism of Anti-Cancer Activity of Curcumin on Androgen-Dependent and Androgen-Independent Prostate Cancer
Q42184292Molecular markers for prostate cancer in formalin-fixed paraffin-embedded tissues
Q36360770Polymorphisms of BCL2 and BAX Genes Associate with Outcomes in Advanced Non-small cell lung cancer Patients treated with platinum-based Chemotherapy
Q41970044The acute lymphoblastic leukemia prognostic scoring whether it is possible by BCL-2, BAX gene promoter genotyping
Q34502603Therapeutic mechanism of treating SMMC-7721 liver cancer cells with magnetic fluid hyperthermia using Fe₂O₃ nanoparticles
Q91942429Tumor-Specific Induction of the Intrinsic Apoptotic Pathway-A New Therapeutic Option for Advanced Prostate Cancer?

Search more.